Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's How Moderna Could Top $450 Again

TheMotleyFool

0 0

Moderna (NASDAQ: MRNA) shares have dropped 70% since their record high of more than $450 last August. There are a couple of reasons. The first has to do with the general investment environment: Investors aren't flocking to vaccine stocks as they did earlier in the pandemic. The second reason has to do with Moderna specifically. The company's only commercialized product right now is the coronavirus vaccine, so investors worry about earnings if vaccine demand drops in a post-pandemic world.

Does this mean Moderna's shares never will take off again? Not necessarily -- Moderna stock could even top its record high. And here are three factors that could help that happen.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Teilen